PHARMAC documents that matched your search:
...hydrogen peroxide (Crystacide), capsaicin cream (Zostrix HP), sodium alginate (Acidex) and procarbazine hydrochloride (Natulan) in the Pharmaceutical Schedule.
PHARMAC, AstraZeneca finalise agreement on goserelin
(1 page, 52 KB)
PHARMAC and AstraZeneca have finalised an agreement for the prostate and breast cancer drug goserelin (Zoladex)...
PHARMAC Operating Policies & Procedures, 3rd Edition - January 2006
(13 pages, 143 KB)
PHARMAC’s role is to manage the Government’s expenditure on subsidies for pharmaceuticals used in the community and on the procurement of pharmaceuticals provided to patients for use while in hospital. Its role includes activities relating to the supply of pharmaceuticals (for example, negotiating with pharmaceutical companies over the subsidisation or procurement of their products) and activities influencing the demand for pharmaceuticals (for example, promoting appropriate prescribing and best practice initiatives).
People with prostate cancer and breast cancer will continue to have fully funded access to the hormonal treatment goserelin (Zoladex) following an agreement between Government drug-funding agency PHARMAC and pharmaceutical company AstraZeneca...
PHARMAC is disappointed at the knee-jerk reaction of a drug multinational that will deprive New Zealanders of a medicine to treat prostate cancer and breast cancer, Chief Executive Wayne McNee says...
One of the hallmarks of PHARMAC’s work over the past 12 years has been its ability to provide more access to new medicines while continuing to manage funding within the budget provided by District Health Boards. The 2005 year was no exception...